baber/WOPTO huggingface dataset:
Patent DE-03808454-T1 (DE)
Title: Verfahren zur voraussage der auswirkung der her2-gezielten therapie
Inventor: BACUS S
IPC: G01N33/574
Filed: 2003-12-11
Abstract: Verfahren
zum Identifizieren eines Säugetiertumors,
der auf eine HER2-gerichtete Therapie reagiert, wobei der Säugetiertumor
HER2 überexprimiert, wobei
das Verfahren die Stufe des Testens einer aus dem Säugetiertumor
erhaltenen Probe umfasst, um ein Muster einer Expression, einer
Phosphorylierung oder sowohl einer Expression als auch einer Phosphorylierung
von einem oder einer Mehrzahl von Polypeptiden nachzuweisen, bestehend
aus  (a) IGFR-Polypeptid;  (b) EGFR-Polypeptid;  (c)
NDF-Polypeptid;  (d) phosphoryliertem ribosomalem S6-Polypeptid;  (e)
phosphoryliertem AKT-Polypeptid; und  (f) phosphoryliertem ERK-Polypeptid;  wobei
das nachgewiesene Muster der Expression, der Phosphorylierung oder
sowohl der Expression als auch der Phosphorylierung Säugetiertumoren
identifiziert, die auf eine HER2-gerichtete Therapie reagieren.
Patent ES-2055679-T1 (ES)
Inventor: BREHM HELMUT
IPC: C08F291/00
Filed: 1991-07-02
Abstract: PCT No. PCT/EP91/01232 Sec. 371 Date Jun. 7, 1993 Sec. 102(e) Date Jun. 7, 1993 PCT Filed Jul. 2, 1991 PCT Pub. No. WO92/01008 PCT Pub. Date Jan. 23, 1992.The present invention relates to a process for the production of water-swellable products, using very fine particles of water-swellable polymers, characterized by the following steps: a) the very fine particles of water-swellable polymer are dispersed in a monomer which is liquid at room temperature and does not cause the polymeric superfines to swell, b) the dispersion obtained in step a) is mixed with an aqueous monomer solution, c) the mixture obtained in step b) is polymerized by the addition of catalysts and/or by exposure, and d) the polymer gel is comminuted and dried. The present invention further relates to a water-insoluble, water-swellable polymer which absorbs aqueous and serous liquids and blood, and is obtained by the process described above.
Patent ES-2041631-T1 (ES)
Title: Procedimiento para el reacondicionamiento de guarniciones de freno y de embrague.
IPC: F16D69/02
Filed: 1992-10-30
Abstract: PARA EL TRATAMIENTO DE FORROS DE FRENOS Y EMBRAGUES, YA NO UTILIZABLES, SE PROPONE SEPARAR LOS FORROS Y LIMPIARLOS. A CONTINUACION SE SEPARAN LOS SOPORTES Y LOS FORROS. LOS SOPORTES VERIFICADOS EN RELACION A LA EXACTITUD DE LA MEDIDA Y A LAS PROPIEDADES DE RESISTENCIA, SON PREPARADOS PARA LOS NUEVOS REVESTIMIENTOS, MIENTRAS QUE LOS FORROS DE DESECHO Y LOS RESIDUOS OCASIONADOS POR EL TRATAMIENTO, SON AÑADIDOS A FUNDIDOS DE COLADA Y DE ACERO, COMO MATERIAL SUPLEMENTARIO, Y ASI SON EVACUADOS.
Patent ES-2083938-T1 (ES)
Inventor: ADAMSKI BRIAN C
IPC: B65H18/26
Filed: 1994-04-28
Abstract: A method and apparatus for reeling a traveling web, such as paper produced on a paper-making machine, includes a pair of spaced, horizontally disposed rails for supporting one or more reel spools. One of the reel spools is rotated to bring it up to machine speed. A support drum is moved translationally substantially vertically from beneath the rotating reel spool to engage it along a nip line of contact. The on-coming web is directed into the nip of the rotatably driven reel spool to begin the web reeling process to build a wound web roll. The support drum remains in contact with the wound web roll building upon the reel spool continuously until the desired wound web roll diameter is attained. The reel spool/wound web roll is maintained under the control, or influence, of three forces at all times during the formation of the wound web roll: 1) torque from a drive attached to the reel spool, 2) nip pressure from the support drum, 3) web tension of the web coming onto the driven reel spool. The support drum preferably partially supports the wound web roll at all times during the reeling process, and the wound web roll remains horizontal on the support rails at all times as the wound web roll is formed.
Patent ES-2148119-T1 (ES)
Inventor: GILLET PASCAL
IPC: B25B25/00
Filed: 1997-12-16
Abstract: A device for the remote handling of equipment (4) for instance designed for mounting elastic rings (6) comprises a fixed jaw (8) and a mobile jaw (12) which moves linearly relative to the fixed jaw (8) by actuating elements coupled to the equipment (4) by a cable (2) connected to the mobile jaw (12) inside a sheath (3) one end of which comes to stop (10) on the fixed jaw (8). The actuating elements consist of two branches (13, 14) articulated on a common axis (15) such that the distance between their free end (131, 141) is not less than the maximum displacement of the mobile jaw (12), when bringing closer the two handles (16, 17) respectively integral with the two branches (13, 14) of which the free end (131) of one (13) acts as a stop to the other end of the sheath (3) while allowing the cable (2) that is connected to the free end (14) of the other arm (14) to slide.
Patent CY-1111171-T1 (CY)
Inventor: ENTWISTLE DAVID ANDREW
IPC: C07D487/04
Filed: 2011-02-08
Abstract: The invention comprises (1) anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide, (2) pharmaceutical compositions comprising at least one such form, (3) methods for the treatment of a phosphodiesterase-5-mediated condition using at least one such form, and (4) methods for preparing such forms. The compound N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide has the following structure (I).
Patent CY-1111783-T1 (CY)
Inventor: LEONARDI AMEDEO
IPC: A61P13/10
Filed: 2011-08-26
Abstract: The invention relates to a method of treating at least one symptom of lower urinary tract disease in a subject in need of treatment comprising administering to said subject a combination of an alpha<SUB>2</SUB>delta calcium channel subunit (A2d) ligand and a non-steroidal anti-inflammatory drug (NSAID), wherein the administered amounts of A2d ligand and NSAID together comprise a therapeutically effective amount of an active combination of agents. The combination of A2d ligand and NSAID can result in a synergistic therapeutic effect, wherein the combined effect is greater than the additive effect resulting from separate, single administration of A2d ligand or NSAID. Combination of A2d ligand and NSAID is particularly useful in treatment of lower urinary tract disease which manifests symptoms of urinary incontinence.
Patent CY-1111886-T1 (CY)
Inventor: VAN BERKEL PATRICK HENDRIKUS CORNELIS
IPC: C07K16/32
Filed: 2011-09-23
Abstract: The invention provides methods for producing mixtures of antibodies from a single host cell clone. Thereto, a nucleic acid sequence encoding a common light chain, and nucleic acid sequences encoding two different heavy chains are expressed in a recombinant host cell. The antibodies in mixtures according to the invention comprise two different heavy chains capable of pairing to a common light chain, thereby forming functional antigen binding domains. Mixtures of antibodies, and use of these mixtures in a variety of field, are also provided by the invention.
Patent CY-1113468-T1 (CY)
Title: Κονιωδες σκευασμα για βαλγανκικλοβιρη
Inventor: BACHYNSKY MARIA OKSANA
IPC: A61K9/16
Filed: 2012-11-12
Abstract: Η παρούσα εφεύρεση παρέχει νέες στερεές φαρμακευτικές μορφές δοσολογίας υδροχλωρικής βαλγανκικλοβίρης για χορήγηση από το στόμα, μετά από ανασύσταση σε νερό. Αυτές οι νέες φαρμακευτικές μορφές δοσολογίας είναι χρήσιμες για την θεραπευτική αγωγή ή τον έλεγχο ιών του ιού του απλού έρπητα και το κυτταρομεγαλοϊού.
Patent CY-1113922-T1 (CY)
Title: Διαταξη για την παραγωγη βιοαεριου
Inventor: EGGERSMANN KARLGÜNTER
IPC: C12M1/04
Filed: 2013-04-09
Abstract: Μια διάταξη για την παραγωγή βιοαερίου παρουσιάζει τουλάχιστον έναν ζυμωτήρα (1) για την υποδοχή ενός υποστρώματος (2) για την διήθηση, ακόμη ένα δοχείο διηθήματος (3). Ο ζυμωτήρας (1) και το δοχείο διηθήματος (3) διασυνδέονται μεταξύ τους με τέτοιο τρόπο, ώστε το διήθημα που κατεισδύει στο ζυμωτήρα (1) μέσω του υποστρώματος (2) να καταλήγει στο δοχείο διηθήματος (3) και από εκεί να επαναφέρεται ενδεχομένως πάλι πίσω στον ζυμωτήρα (1). Τουλάχιστον μερικώς από την άλλη πλευρά μιας επιφάνειας πυθμένα (1a) του ζυμωτήρα (1) τοποθετείται ένα ρεζερβουάρ θερμότητας (3) και/ή μια συσκευή συλλογής διηθήματος (5).
Patent CY-1117410-T1 (CY)
Title: Κρυσταλλικη μορφη ενος ηλεκτρικου αλατος
Inventor: HOWSHAM CATHERINE
IPC: C07D471/10
Filed: 2016-04-19
Abstract: Αυτή η εφεύρεση σχετίζεται με μία νέα κρυσταλλική μορφή του ηλεκτρικού άλατος του αναστολέα του επιθηλιακού διαύλου νατρίου(ENaC) 3-(3-{2-[(Ε)-3,5-διαμινο-6-χλωρο-πυραζίνη-2-καρβονυλιμινο]-1,3,8-τριαζο-σπιρο[4.5]δεκανιο-8-καρβονυλ}-βενζολο σουλφονυλαμινό) προπιονικό διπροπυλοκαρβαμοϋλομεθυλεστέρα, με τις φαρμακευτικές συνθέσεις που περιλαμβάνουν την εν λόγω κρυσταλλική μορφή, με τις χρήσεις της εν λόγω κρυσταλλικής μορφής και των φαρμακευτικών συνθέσεων και με τις μεθόδους για την παρασκευή της εν λόγω κρυσταλλικής μορφής.
Patent CY-1117607-T1 (CY)
Title: Μεθοδος μεταδοσης για την εξ αποστασεως αναγνωση μετρητων ρευστου
Inventor: FARNIER ERIC
IPC: H04Q9/00
Filed: 2016-05-20
Abstract: Μέθοδος μετάδοσης για την εξ αποστάσεως ανάγνωση μετρητών ρευστών, σύμφωνα με την οποία ένας μετρητής περιλαμβάνει ένα δομοστοιχείο (Ε31), (Ε32), (E33), (Ε34), (E35) με δυνατότητα μετάδοσης, στη ζώνη συχνοτήτων VHF, ενός πλαισίου δεδομένων από εξ αποστάσεως ανάγνωση σε ένα διακομιστή (Ε1) που περιλαμβάνει ένα ραδιοδέκτη με δυνατότητα λήψης στη ζώνη συχνοτήτων UHF. Σύμφωνα με την εν λόγω μέθοδο, ένας συγκεντρωτής (Ε21), (Ε22) λαμβάνει το πλαίσιο δεδομένων από το δομοστοιχείο (Ε31), (Ε32), (Ε33), (Ε34), (Ε35) στη ζώνη συχνοτήτων VHF και μεταδίδει το εν λόγω πλαίσιο δεδομένων στη ζώνη συχνοτήτων UHF στο διακομιστή (Ε1).
Patent CY-1119404-T1 (CY)
Title: Υδροξυλ ενωσεις και συνθεσεις για χειρισμο χοληστερολης και σχετικες χρησεις
Inventor: DASSEUX JEAN-LOUIS HENRI
IPC: C07C311/24
Filed: 2017-09-26
Abstract: Η παρούσα εφεύρεση αφορά σε νέες υδροξύλ ενώσεις, συνθέσεις που περιλαμβάνουν υδροξύλ ενώσεις και μεθόδους χρήσιμες για θεραπεία και αποτροπή μιας ποικιλίας ασθενειών και καταστάσεων όπως, αλλά μη περιοριζόμενες σε αυτές, γήρανσης, ασθένειας Alzheimer, καρκίνου, καρδιαγγειακής νόσου, διαβητικής νεφροπάθειας, διαβητικής αμφιβληστροειδοπάθειας, διαταραχής μεταβολισμού γλυκόζης, δυσλιπιδαιμίας, δυσλιποπρωτεϊναιμίας, υπέρτασης, ανικανότητας, φλεγμονής, αντίστασης ινσουλίνης, απομάκρυνσης λιπιδίου στη χολή, παχυσαρκίας, απομάκρυνσης οξυστερόλης στη χολή, παγκρεατίτιδας, οξείας παγκρεατίτιδας, ασθένειας Parkinson, διαταραχής που συνδυάζεται με υποδοχέα που ενεργοποιείται από πολλαπλασιαστή περοξυσώματος, απομάκρυνσης φωσφολιπιδίου σε χολή, νεφρικής νόσου, σηψαιμίας, διαταραχών μεταβολικού συνδρόμου (π.χ. Συνδρόμου Χ), θρομβωτικής διαταραχής. Ενώσεις και μέθοδοι της εφεύρεσης μπορεί επίσης να χρησιμοποιηθούν για να ρυθμίζουν C αντιδρώσα πρωτεΐνη ή να ενισχύουν παραγωγή χολής σε έναν ασθενή. Σε ορισμένες πραγματοποιήσεις, οι ενώσεις, οι συνθέσεις και οι μέθοδοι της εφεύρεσης είναι χρήσιμες σε θεραπεία συνδυασμού με άλλα θεραπευτικά-όπως υποχοληστερολαιμικούς και υπογλυκαιμικούς παράγοντες.
Patent CY-1125405-T1 (CY)
Title: Ενωσεις 2-(2,4,5-υποκατεστημενης-ανιλινο) πυριμιδινης
Inventor: BUTTERWORTH SAM
IPC: C07D401/02
Filed: 2021-11-17
Abstract: Η παρούσα εφεύρεση αναφέρεται σε συγκεκριμένες ενώσεις 2-(2,4,5-υποκατεστημένης-ανιλινο) πυριμιδίνης και σε φαρμακευτικώς αποδεκτά άλατα αυτών, που μπορεί να είναι χρήσιμα στη θεραπευτική αντιμετώπιση ή πρόληψη μίας πάθησης ή ιατρικής κατάστασης που προκαλείται από συγκεκριμένες μεταλλαγμένες μορφές του υποδοχέα του επιδερμικού αυξητικού παράγοντα (για παράδειγμα το μετάλλαγμα ενεργοποίησης L858R, το μετάλλαγμα ενεργοποίησης Exon19 διαγραφής και το ανθεκτικό μετάλλαγμα Τ790Μ). Αυτές οι ενώσεις και τα άλατα αυτών μπορεί να είναι χρήσιμα στη θεραπευτική αντιμετώπιση ή πρόληψη ενός αριθμού διαφορετικών καρκίνων. Η εφεύρεση επίσης αναφέρεται σε φαρμακευτικές συνθέσεις που περιλαμβάνουν τις εν λόγω ενώσεις και τα άλατα αυτών, κυρίως χρήσιμες πολυμορφικές μορφές αυτών των ενώσεων και αλάτων, ενδιάμεσες ενώσεις χρήσιμες στην παρασκευή των εν λόγω ενώσεων και σε μεθόδους θεραπευτικής αντιμετώπισης παθήσεων που προκαλούνται από διάφορες, διαφορετικές μορφές του EGFR, χρησιμοποιώντας τις εν λόγω ενώσεις και τα άλατα αυτών.
Patent GR-980300015-T1 (GR)
Title: PROCESS FOR PRODUCING DERIVATIVES OF 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO 3a,3,2-ef] 2]BENZAZEPINE
Inventor: CZOLLNER LASZLO
IPC: C07D491/153
Filed: 1998-03-31
Abstract: The invention relates to processes for the preparation of 4a,5,9,10,11,12-hexahydro-6H-benzofuro(3a,3,2-ef)(2)benzazepine, or derivatives thereof. Furthermore, the invention also relates to the compounds formed during the preparation of 4a,5,9,10,11,12-hexahydro-6H-benzofuro(3a,3,2-ef)(2)benzazepine.
Patent HR-P20100022-T1 (HR)
Inventor: FINCH CHARLES W
IPC: A01N43/40
Filed: 2010-01-13
Abstract: Formulacija koncentrata za emulziju (EC), naznačena time što sadržia)	spoj fenilsemikarbazona formule (I), gdje su R1 i R2, međusobno nezavisno, vodik, cijano, halogen, C1-C4-alkil, C1-C4-alkoksi, C1-C4-haloalkil ili C1-C4-haloalkoksi i R3 je C1-C4-alkoksi, C1-C4-haloalkil ili C1-C4-haloalkoksi, ili njegovu poljoprivredno prihvatljivu sol, b)	sustav otapala, koji sadržib1)	γ-butirolakton, b2)	jedan ili više alifatičnih i/ili aromatičnih ketona, ib3)	izborno jedan ili više aromatičnih ugljikovodikac)	jedan ili više emulgatora, d)	izborno, dodatne aditive za formulaciju. Patent sadrži još 11 patentnih zahtjeva.
Patent SI-1120505-T1 (SI)
Title: A building block suitable for the construction of dry-stacking high performance masonry walls
Inventor: GRAY JOHN E
IPC: E04B2/02
Filed: 2001-01-26
Abstract: A pre-cast modular block 1 for construction of walls by dry-stacking comprises two outer walls 2 and two inner walls 3. Each outer wall 2 is connected to its adjacent inner wall 3 by cross-walls 4 defining voids 5. The inner walls 3 are connected by cross-walls 6 which define a void 7 and open-ended formations 8. V-shaped grooves 10 and 11 are provided in the cross-walls 5 and 6 respectively. The upper surfaces 12 of the outer walls 2 are below the level of the upper surfaces 13 and are provided with bosses 14 which at their tops are level with surfaces 13. Vertical rebates 17 are provided in the outer walls 2 at each side edge thereof. The bosses 14 provide for stability during dry-stacking of the bosses and serve to define horizontal bed joints, vertical joints being defined by the rebate 17. Horizontal and vertical bands of reinforced concrete may be provided in the wall for stability thereof. <IMAGE>
Patent SI-1341515-T1 (SI)
Title: Water-free skin care formulations comprising micronized urea and method of manufacturing the same
Inventor: FRANKE PATRICK
IPC: A61K8/00
Filed: 2001-12-14
Abstract: The invention provides novel water-free medical skin care formulations comprising micronized urea dispersed in a fatty phase. The fatty phase consists essentially of hydrocarbons and is essentially free from ingredients with known allergenic potential such as perfumes or perfume substitutes (fragrances), preservatives, colorings, plant extracts, PEGs, cetylstearyl alcohol, lanolin alcohols, lower alcohols, and proteins, thus being particularly suitable for patients with highly sensitive skin. The formulations of the invention have favorable sensorial properties and are stable for an extended period of time. The formulations are suitable for medical skin care, such as for the treatment of severely affected dry, sensitive skin and for the therapy or therapy support of ichthyosis, psoriasis, and eczema. The invention also provides methods of manufacturing such water-free skin care formulations.
Patent SI-1565573-T1 (SI)
Title: Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used
Inventor: ROTH STINA
IPC: C12Q1/689
Filed: 2003-11-19
Abstract: The invention relates to nucleic acid probes and to broad-range primers that are useful in the identification of bacterial species and the diagnosis of bacterial infections. Especially, the invention relates to specific nucleic acid probes that originate from hyper-variable regions situated near the conserved sequences of topoisomerase genes of infection-causing bacteria. The invention also relates to broad-range primers originating from the conserved regions of topoisomerase genes. In addition, the invention relates to the use of these nucleic acid probes and broad-range primers in the diagnosis of bacterial infections as well as to diagnostic methods in which these nucleic acid probes and broad-range primers are used.
Patent SI-1513279-T1 (SI)
Title: Data encryption on the physical layer of a data transmission system
Inventor: DZUNG DACFEY
IPC: H04L27/00
Filed: 2003-09-08
Abstract: The present invention is concerned with a method to encrypt OFDM modulation, by multiplying its underlying QAM symbols by a complex-valued generalized key stream sequence. Performing encryption on the physical layer ensures that all services and applications running over the OFDM modem will be protected against eavesdropping. It is also proposed to include in the encryption any training symbols used for synchronization and channel estimation. Only the legitimate receiver knowing the encryption key is hence able to synchronize and correctly demodulate the received signal. Attackers will not even be able to acquire the encrypted signal. <IMAGE>
Patent SI-1749486-T1 (SI)
Title: Swing gate for device lockout in a curved cutter stapler
Inventor: KELLY WILLIAM D
IPC: A61B17/00
Filed: 2006-08-04
Abstract: A linear surgical stapler adapted for applying a plurality of surgical fasteners to body tissue includes an anvil structure and a cartridge housing containing a plurality of surgical fasteners. The cartridge housing and anvil structure are relatively movable between a first spaced apart position and a second position in close approximation with one another. A firing mechanism is associated with the cartridge housing for ejecting the surgical fasteners from the cartridge housing to be driven against the anvil structure. A lockout mechanism interacts with the cartridge housing for selective activation and deactivation. The lockout mechanism includes a swing gate tab secured to the cartridge housing at a position adjacent a lockout lever, such that firing of the linear surgical stapler rotates the swing gate tab releasing the lockout lever for preventing further firing of the used cartridge housing.
Patent SI-2307360-T1 (SI)
Title: Method for producing molded bodies using mixtures of amines with guanidine derivatives
Inventor: DAUN GREGOR
IPC: C07C279/00
Filed: 2009-07-17
Abstract: The present invention provides a process for producing moldings, the curing of the mold being carried out using a blend comprising one or more epoxy resins and a mixture, the curing component a) being used within the mixture in the range from 0.3 to 0.9 amine equivalent per equivalent of epoxide of the epoxy resin used, and the hardener component b) being a compound of the formula I.
Patent SI-2681192-T1 (SI)
Title: Synthesis of 2-carboxamide cycloamino urea derivatives
Inventor: ERB BERNHARD
IPC: C07D417/00
Filed: 2012-03-01
Abstract: Provided herein are processes and intermediate compounds useful for the preparation of 2-carboxamide cycloamino urea derivatives, and useful intermediates therefore.
Patent TR-200002813-T1 (TR)
Title: Türetilmiş mikrofibriler polisakkarit.
Inventor: CASH MARY JEAN
IPC: A23L29/20
Filed: 2000-02-08
Abstract: Bir polisakarit  baslatma materyalinin stabilize edilmesi ve/veya mikrofibrillenmesi yoluyla, elektrostatik güçlerin anyonik sarjla ya da hen anyonik hem de katiyonik sarjin bir kombinasyonuyla elde edildigi sterik ve/veya elektrostatik güçler tarafindan türetilen, onunla sinirli olmamak üzere selülozu da içeren türetilmis mikrofibriler polisakarit üretmeye yönelik bir yöntem. Tüterilmis mikrofbriler polisakarit kullanarak maddenin bir bilesiminin reolojik özelliklerini modifiye eden bir yöntem. Türetilmis mikrofibriler bir poliskarit kullanarak kaplamalarin ve kagit üretiminin gelistirilmesine ve emülsiyonlarin, dagilimlarin ve köpüklerim dayanikliliginin artirilmasina yönelik bir yöntem. Kagit bilesimleri, yenilebilir bilesimler, yenilemez bilesimler, sürülerek kullanilan bilesimler ve emülsiyonlar, dagilim ve köpükleri kapsayan türetilmis mikrofibriler polisakkarit içeren bilesimler.
Patent GR-20010300071-T1 (GR)
Title: Polymers for cement dispersing admixtures
Inventor: VELTEN ULF
IPC: C08G81/02
Filed: 2001-12-31
Abstract: Polymers for cement dispersing admixtures, which show different performing properties in concrete are described. All polymers are based on a composition of reactants, namely a) a poly(acrylic acid), b) a polyalkyleneglycol-monoalkylether and, optionally c) a  alpha -amino-polyalkyleneglycol- omega -alkylether and/or d) a primary or secondary amine. By keeping the composition of reactants constant and varying only the reaction time, polymers with different properties can easily be achieved. Such polymers are suitable for precast, readymix or for increasing workability over time, just depending on reaction time. Polymers of the invention can be used as single polymer or in polymer blends. For this, the kinetics of the used polymer analogous condensation reaction was intensively studied. Additionally, the benefit of amines as reactant regarding stability and hydrolysis velocity of cleavable side groups was investigated.
Patent DE-3686483-T2 (DE)
Inventor: ALMINGER TOMAS BOERJE
IPC: C07D401/00
Filed: 1986-10-28
Granted: 1993-02-04
Abstract: Novel compounds of the formula <CHEM> pharmaceutical compositions containing such compounds as active ingredient, and the use of the compounds in medicine.
Patent DE-3780648-T2 (DE)
Inventor: HOSHINO RYOICHI
IPC: F28F1/02
Filed: 1987-07-27
Granted: 1992-12-17
Abstract: A condenser (10) for use in a car cooling system, comprising a pair of parallel headers (13, 14), a plurality of tubular elements (11) whose opposite ends are connected to the headers (13, 14) and fins (12) provided in the air paths between adjacent tubular elements (11), each of the headers (13, 14) being made of a cylindrical pipe of aluminum and each of the tubular elements (11) being made of a flattened hollow tube of extruded aluminum, the opposite ends of the tubular elements (11) being inserted into slits (15) provided in the headers (13, 14) and soldered therein so as to be liquid-tight.
Patent DE-3786966-T2 (DE)
Inventor: PERREGAARD JENS KRISTIAN
IPC: C07D211/52
Filed: 1987-09-03
Granted: 1994-03-17
Abstract: The novel acetic acid ester of 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-bu tanone (Haloperidol) as well as acid addition salts thereof are described, and a method of preparation of said compounds. Pharmaceutical compositions containing one of said compounds are described in form of injectable solutions in oils, e.g. sesame oil and light vegetable oil, which have advantages compared with known solutions of haloperidol.
Patent DE-3878602-T2 (DE)
Inventor: SASAKI TAKESHI
IPC: B23B5/08
Filed: 1988-06-27
Granted: 1993-07-15
Abstract: When rolls (5) in a rolling mill are repaired, a roll stand (2) is first dismounted from the rolling mill. Then the dismounted roll stand is secured and the rolls are pressed against the housing (4) of the roll stand in the axial direction of the roll for eliminating of the clearance. In this situation the rolls are cut. After the rolls have been cut, the roll stand is released from being secured. Then the roll stand is mounted on the rolling mill.   A cutting apparatus used for cutting rolls comprises a base frame (32) and a stand (33) mounted on the base frame for placing the roll stand (2) thereon. The housing (4) of the roll stand placed on the stand is secured against the base frame. Furthermore, the rolls (5) of the roll stand are brought near to the housing in the axial direction of the roll and are located. In the situation located against the housing, the rolls are rotated by a roll rotating apparatus (38) and cut with a cutting tool (90).